Consulting & marketing company with focus in pharmaceutical industry became a business partner with exclusive rights to promote and commercialize the Products registered by Tolmar, Inc.• Responsible for operational activity of the company in Russia & Kazakhstan• Sales, commercial strategy, pricing & agreement terms, cashflow management

Reported to the Head of Representative Office, Business volume $4M, # of direct reporters 12• Manager of Managers• Commercial strategy, pricing & agreement terms, cashflow management• New business development, e.g. portfolio extension (including OTX) and new markets launch (Uzbekistan, Belorussia)• Head of business in Kazakhstan

Reported to Market Access Director• Market access strategic and operational processing in accordance with overall company goals• Building strong relationships with Key Opinion Leaders, authorities, professional and patient societies to get support in dedicated therapeutic area• Lead joint projects with stakeholders in therapeutic area to shape the external environment in favor of virology portfolio• Value creation based on Marketing, Medical and Health Economy input

Reported to the Head of Strategic Department, Business Volume $5-7M, # of direct reporters 5• Product contribution responsibility for Oncology Portfolio• Value creation based on Marketing, Medical and Market Access input • Strategic and operational processing in accordance with overall company goals• Life cycle management• Member of the Operational Board

Reported to the Head of Health Economic / Market Access / Reimbursement and then to the Head of Specialized Care Department, Business Volume $5-40M, # of direct reporters up to 45• P&L responsibility for Oncology Portfolio• Cross functional leadership of Marketing, Medical, Health Economics and Market Access • Strategic and operational business planning in accordance with overall company goals• Experience in new business development, new product acquisition and launch• Lead in Market Access projects focused on advocacy platform and governmental partnership initiatives• Commercial Strategy development, including financial conditions and cooperation programs • Organizational leadership, including team management of 45 employees, talent management, sales force efficiency and deployment

Reported to Franchise Head Oncology, Business volume $40-45M, one direct reporter (as a part of development plan)• Development and implementation of brand strategy for Eprex and Durogesic• P&L processing (budget, commercial policy, pricing strategy, investment level to ensure product profit)• Coaching junior staff in key developmental areas• Development of franchise strategy (build product portfolio, SF efficiency & deployment)• EMEA Marketing Team Member• Customer and Industry Networking

Reported to Franchise Head Oncology, Business volume $15-45M, no direct reporters• Development of marketing strategy (alignment with J&J Global Marketing Platform, launch of country promotion campaign)• New products launch (line extension for Eprex, Yondelis)• Budgeting (business & strategic planning process leader for Oncology brands)• Market analysis and forecast • Key Opinion Leaders Networking• Product trainings for specialized field force • Promotional activity (multi-channel platform) • Experience in Life Cycle Management (LLCM, biosimilar concept)